Abstract
Percutaneous balloon mitral valvuloplasty (PBMV) described by Inoue et al, is a safe FDA (Food and Drug Administration) approved procedure in patients with severe mitral stenosis. One of the contraindications of the procedure is presence of a left atrial thrombus; however, it has been reported that intense warfarin therapy may led to dissolution of the thrombus. The authors report a patient who was referred for PBMV and was found to have a left atrial thrombus. After intense warfarin therapy, successful PBMV was undertaken without complications.
Original language | English |
---|---|
Pages (from-to) | 255-259 |
Number of pages | 5 |
Journal | Angiology |
Volume | 50 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1999 |
Externally published | Yes |